描述 |
Zofenopril Calcium(SQ26991)是抗氧化剂和血管紧张素转化酶(ACE)抑制剂。 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
相关类别 |
|
||||||||||||
溶解度 |
体外:
DMSO:2 mg / mL(4.46 mM;需要超声波)
|
||||||||||||
储备液 |
|
||||||||||||
存储 |
|
||||||||||||
运输 |
室温;可能会有所不同 |
||||||||||||
SMILES |
O=C(N(C[C@@H](SC1=CC=CC=C1)C2)[C@@H]2C([O-])=O)[C@H](C)CSC(C3=CC=CC=C3)=O.[0.5Ca2+] |
||||||||||||
参考文献 |
|
||||||||||||
相关活性 小分子 |
天冬氨酰-精氨酰-缬氨酰-酪氨酰-异亮氨酰-组氨酰-脯氨酸 | 卡托普利 | 马来酸依那普利 | 培哚普利 | 赖诺普利 | Phosphoramidon Disodium | 群多普利 | 福辛普利钠 | 喹那昔利 | 雷米普利 | 西拉普利 | 依那普利那二水 | 奥马曲拉 | 盐酸替莫普利 | 血啡-7 |
密度 | 1.34 g/cm3 |
---|---|
沸点 | 646.3?C at 760 mmHg |
熔点 | >250?C |
分子式 | C22H22Ca0.5NO4S2 |
分子量 | 448.58 |
闪点 | 344.7?C |
PSA | 228.56000 |
LogP | 7.80660 |
外观性状 | 白色或发白的结晶粉末 |
储存条件 | Refrigerator |
|
符号 |
GHS09 |
---|---|
信号词 |
Warning |
危害声明 |
H410 |
警示性声明 |
P273-P501 |
危害码 (欧洲) |
N |
风险声明 (欧洲) |
50/53 |
安全声明 (欧洲) |
60-61 |
危险品运输编码 | UN 3077 9 / PGIII |
~%
佐芬普利钙
81938-43-4
|
文献:WO2007/3963 A1, ; Page/Page column 9; 11-12 ; |
~%
佐芬普利钙
81938-43-4
|
文献:US2009/176860 A1, ; Page/Page column 3 ; |
~%
佐芬普利钙
81938-43-4
|
文献:WO2010/84515 A2, ; Page/Page column 34 ; |
~%
佐芬普利钙
81938-43-4
|
文献:WO2010/84515 A2, ; Page/Page column 33-34 ; |
佐芬普利钙上游产品? 3 | |
---|---|
|
|
佐芬普利钙下游产品? 0 |
Zofenopril plus hydrochlorothiazide fixed combination in the treatment of hypertension and associated clinical conditions. Cardiovasc. Ther. 27(4) , 275-88, (2009)
Zofenopril, is a highly lipophilic ACE inhibitor, characterized by long-lasting tissue penetration and sustained cardiac ACE inhibition, indicated for the treatment of hypertension and myocardial infa...
|
|
Development and validation of a liquid chromatography-tandem mass spectrometry method for the determination of zofenopril and its active metabolite zofenoprilat in human plasma. J. Pharm. Biomed. Anal. 55(3) , 527-32, (2011)
A novel, sensitive and rapid liquid chromatographic-electrospray ionization mass spectrometric method was developed and validated for the determination of zofenopril and its active metabolite zofenopr...
|
|
Effects of zofenopril and ramipril on cough reflex responses in anesthetized and awake rabbits. J. Cardiovasc. Pharmacol. Ther. 15(4) , 384-92, (2010)
Cough is the most common symptom reported by patients in a primary care setting and is one of the most frequent secondary effects recorded during treatment with angiotensin-converting enzyme (ACE) inh...
|
|
Calcium bis[(2S,4S)-1-[(2S)-3-(benzoylsulfanyl)-2-methylpropanoyl]-4-(phenylsulfanyl)-2-pyrrolidinecarboxylate] |
ZOFENOPRIL CALCIUM |
Calcium bis[(2S,4S)-1-[(2S)-3-(benzoylsulfanyl)-2-methylpropanoyl]-4-(phenylsulfanyl)pyrrolidine-2-carboxylate] |
L-Proline, 1-[(2S)-3-(benzoylthio)-2-methyl-1-oxopropyl]-4-(phenylthio)-, calcium salt, (4S)- (2:1) |
MFCD08704648 |
Zofenopril calcium salt |